Stockholders’ Deficit (Details)	1 Months Ended			12 Months Ended
	Apr. 30, 2020 USD ($) shares	Feb. 29, 2020 USD ($) shares	Jan. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized				500,000,000	500,000,000
Preferred stock, shares authorized				2,000,000
Common stock shares			2,010,000
Exercise price per share (in Dollars per Share) | $ / shares			0.07
Option exercise (in Dollars) | $				$ 108,000
Stock-based compensation amount (in Dollars) | $				$ 1,236,806
Series A convertible preferred stock, issued				13,602	13,602
Accured dividends (in Dollars) | $				$ 295,000
Series A convertible preferred stock, liquidation preference (in Dollars per share) | $ / shares				$ 25
Series A convertible preferred stock, dividend rate				6.50%
Weighted average of the last sales prices				95.00%
Dividend rate increase				10.00%
Preferred stock conversion price per share (in Dollars per share) | $ / shares				$ 12
Stockholders equity, description				If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.
Common stock discount shares description				The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.
Reserved a total possible issuance under the plan				50,000,000
Total stock-based compensation expense for grants (in Dollars) | $				$ 1,232,256	$ 1,501,000
Stock based compensation description				The $1,236,806 stock-based compensation for the year ended December 31, 2021, was comprised of $520,819 option expense and $669,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.
Share based compensation of restricted stock agreement shares				140,000
Restricted stock awards value (in Dollars) | $				$ 84,000
Recognized restricted stock awards value (in Dollars) | $				$ 46,987
Restricted stock, grants description				The company issued 140,000 shares through restricted stock grants year ended December 31, 2021, and 2020. The company renewed a consulting agreement, extending services for an additional term of two sequential one-year periods. As compensation for the renewal, Mr. Donaghey is to receive for each year of service during the renewal term 70,000 shares of AERG common stock and options to purchase 200,000 shares of common stock at an exercise price of $0.61 per share, reflecting the fair market value of the common stock on the date of grant. 50% of the options vest on the first anniversary of the renewal, and the other 50% vest on the second anniversary, 50% of the common stock vests immediately and the remaining 50% on the first anniversary of the agreement.
Unrecognized stock based compensation (in Dollars) | $				$ 764,000
Weighted average basis over a period				1 year
Restricted stock agreement shares description				Additionally, stock-based compensation for the year ended December 31, 2021, was comprised of 140,000 shares under a restricted stock agreement the Company entered into in May of 2021. The restricted stock awards were valued at $84,000 of which $46,987 was recognized in 2021.
Business Combination [Member]
Stockholders’ Deficit (Details) [Line Items]
Issuable in acquisition, description				As of December 31, 2021, and December 31, 2020, the company recorded $223,000 and $892,000, respectively, in unrecognized stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months. $669,000 and $669,000 was amortized for the year ended December 31, 2021, and 2020, respectively.
Subscription Agreements [Member]
Stockholders’ Deficit (Details) [Line Items]
Shares Issued	1,770,333
Subscription Agreements (in Dollars) | $	$ 531,000
Private Placement [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				4,054,665
Price per share (in Dollars per share) | $ / shares				$ 0.75
Cash proceeds (in Dollars) | $				$ 3,041,000
Private Placement1 [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				7,056,250
Price per share (in Dollars per share) | $ / shares				$ 0.32
Cash proceeds (in Dollars) | $				$ 2,258,000
Series A Preferred Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Series A convertible preferred stock, issued				13,602	13,602
Liquidation preference				7.50%
Minimum [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference				1.00%
Maximum [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference				6.50%
Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized				500,000,000
Common stock value (in Dollars) | $		$ 510,000	$ 603,000
Common stock shares		1,700,000		158,329
Issue of warrants			25,000
Option exercise (in Dollars) | $				$ 1,650
Shares issued for convertible notes				47,498
Warrant [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				800,000
Warrant Exercise (in Dollars) | $	$ 11,000
Shares Issued	150,000
Option exercise (in Dollars) | $	$ 63,000
Option exercise	900,000
Stock value issued for exercise of warrants				800,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.07
Restricted Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				31,250
Stock value issued for restricted stock agreement (in Dollars) | $				$ 4,550
Warrant One [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				250,000
Stock value issued for exercise of warrants				250,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Warrant Two [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				50,000
Stock value issued for exercise of warrants				50,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Warrant Three [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				100,000
Stock value issued for exercise of warrants				100,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.07
Warrant Four [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				200,000
Stock value issued for exercise of warrants				200,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Warrant Five [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				125,000
Stock value issued for exercise of warrants				125,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Warrant Six [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				60,000
Stock value issued for exercise of warrants				60,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Warrant Seven [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				65,000
Stock value issued for exercise of warrants				65,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.06
Options [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				1,005,682
Common stock option exercise				1,090,910
Stock option exercise price Per share (in Dollars per share) | $ / shares				$ 0.05
Options to purchase common stock				760,000
Common stock exercise price (in Dollars per share) | $ / shares				$ 0.61
Options vest over a period				3 years
Options One [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				259,741
Common stock option exercise				500,000
Stock option exercise price Per share (in Dollars per share) | $ / shares				$ 0.37
Options to purchase common stock				1,000,000
Common stock exercise price (in Dollars per share) | $ / shares				$ 0.19
Options vest over a period				3 years
Options Two [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				475,000
Common stock option exercise				500,000
common stock withheld with exercise				25,000
Options to purchase common stock				155,000
Common stock exercise price (in Dollars per share) | $ / shares				$ 1.21
Options vest over a period				3 years
Options Three [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				482,143
Common stock option exercise				500,000
common stock withheld with exercise				17,857
Option Four [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				728,814
Common stock option exercise				750,000
common stock withheld with exercise				21,186
Option Five [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				400,158
Common stock option exercise				409,090
common stock withheld with exercise				8,932
Option Six [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock shares				731,109
Common stock option exercise				750,000
common stock withheld with exercise				18,891
Preferred Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference				101.00%